Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study
Neri M, Rossi R, Trabanelli C, et al.
Frontiers in Genetics, 2020, 11, p 131
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients
Bonanno S, Marcuzzo S, Malacarne C, et al.
Biomedicines, 2020, 8, 2
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients
Maggi L, Brugnoni R, Canioni E, et al.
Frontiers in neurology, 2020, 11, p 646
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Cavalcante P, Mizrachi T, Barzago C, et al.
Pharmacological Research, 2019, 148
Italian recommendations for diagnosis and management of congenital myasthenic syndromes
Maggi L, Bernasconi P, D'Amico A, et al.
Neurological sciences, 2019, 40, 3, p 457
Myasthenia gravis: from autoantibodies to therapy
Mantegazza R, Bernasconi P, Cavalcante P
Current opinion in neurology, 2018, 31, 5, p 517
Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis
Zanotti S, Zanotti S, Gibertini S, et al.
Matrix biology : journal of the International Society for Matrix Biology, 2018
Elevated TGF Beta2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes
Bernasconi P, Carboni N, Ricci G, et al.
Nucleus (Austin, Tex.), 2018, 9, 1, p 292
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis?acting DNA elements that govern muscle dystrophin expression
Gherardi S, Bovolenta M, Passarelli C, et al.
Biochimica et biophysica acta, 2017, 1860, 11, p 1138
Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features
Maggi L, Carboni N, Bernasconi P
Cells, 2016, 5, 3
Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection
Cavalcante P, Galbardi B, Franzi S, et al.
Immunobiology, 2016, 221, 4, p 516
Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S, Zanotti S, Savadori P, et al.
Cell and tissue research, 2014, 356, 2, p. 427-43
VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis
Avidan N, Le Panse R, Harbo HF, et al.
Annals of clinical and translational neurology, 2014, 1, 5, p 329
LMNA-associated myopathies : The Italian experience in a large cohort of patients
Maggi L, D'Amico A, Pini A, et al.
Neurology, 2014, 83, 18, p 1634
Etiology of myasthenia gravis : innate immunity signature in pathological thymus
Cavalcante P, Cufi P, Mantegazza R, et al.
Autoimmunity reviews, 2013, 12, 9, p. 863-874
Etiology of myasthenia gravis: innate immunity signature in pathological thymus
Cavalcante P, Cufi P, Mantegazza R, et al.
Autoimmunity reviews, 2013, 12, 9, p 863
Autoimmune mechanisms in myasthenia gravis
Cavalcante P, Bernasconi P, Mantegazza R
Current opinion in neurology, 2012, 25, 5, p. 621-629
Inflammation and Epstein-Barr virus infection are common features of myasthenia gravis thymus : possible roles in pathogenesis
Cavalcante P, Maggi L, Colleoni L, et al.
Autoimmune diseases, 2011, 2011, p. 213092
The thymus in myasthenia gravis : site of "innate autoimmunity"?
Cavalcante P, Le Panse R, Berrih-Aknin S, et al.
Muscle & Nerve, 2011, 44, 4, p. 467-484
Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus
Cavalcante P, Serafini B, Rosicarelli B, et al.
Annals of neurology, 2010, 67, 6, p. 726-738
Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis
Cavalcante P, Barberis M, Cannone M, et al.
Neurology, 2010, 74, 14, p. 1118-1126
Risk of arrhythmia in type I myotonic dystrophy : the role of clinical and genetic variables
Cudia P, Bernasconi P, Chiodelli R, et al.
Journal of neurology, neurosurgery and psychiatry, 2009, 80, 7, p. 790-793
Identification of a point mutation in the skeletal muscle ryanodine receptor gene associated in the homozygous state to central core disease (Poster)
Collectif, Melli G, Colleoni L, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 809-810
In vitro dissection of the pathogenic mechanisms of muscle fibrosis in Duchenne muscular dystrophy (Poster)
Collectif, Zanotti S, Saredi S, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 778
Risk of arrhythmia in type 1 myotonic dystrophy: The role of clinical and genetic variables in a large cohort of patients (Poster)
Collectif, Cudia P, Bernasconi P, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 745
